During the past decade, Central Florida Gastro Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Florida Gastro Research" are "Adenoma" (1 trials), "Colon Cancer" (1 trials), "Colon Diseases" (1 trials), "Colon Lesion" (1 trials) and "Colon Neoplasm" (1 trials). Many other conditions were trialed in "Central Florida Gastro Research" in a lesser frequency.

Most popular intervention types in "Central Florida Gastro Research" are "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Freenome test" (1 trials), "Mirikizumab" (1 trials), "Placebo" (1 trials) and "Ustekinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Florida Gastro Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Central Florida Gastro Research". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Central Florida Gastro Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Florida Gastro Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".